Skip to main content
SpringerLink
Log in

Relacorilant, un nuovo bloccante selettivo del recettore dei glucocorticoidi

  • FARMACI INNOVATIVI IN ENDOCRINOLOGIA
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Bibliografia

  1. Brown DR, East HE, Eilerman BS et al. (2020) Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations. Clin Diabetes Endocrinol 6(1):18

    Article  PubMed  PubMed Central  Google Scholar 

  2. Fleseriu M, Biller BM, Findling JW et al. (2012) Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing’s syndrome. J Clin Endocrinol Metab 97(6):2039–2049

    Article  CAS  PubMed  Google Scholar 

  3. Pivonello R, Bancos I, Feelders RA et al. (2021) Relacorilant, a selective glucocorticoid receptor modulator, induces clinical improvements in patients with Cushing syndrome: results from a prospective, open-label phase 2 study. Front Endocrinol (Lausanne) 12:662865

    Article  PubMed  Google Scholar 

  4. Custodio JM, Donaldson KM, Hunt HJ (2021) An in vitro and in vivo evaluation of the effect of relacorilant on the activity of cytochrome P450 drug metabolizing enzymes. J Clin Pharmacol 61(2):244–253

    Article  CAS  PubMed  Google Scholar 

  5. Terzolo M, Iacuaniello D, Pia A et al. (2019) SUN-463 tumor shrinkage with preoperative relacorilant therapy in two patients with Cushing disease due to pituitary macroadenomas. J Endocr Soc 3:SUN-463

    Article  PubMed Central  Google Scholar 

  6. Pivonello R, Munster PN, Terzolo M et al. (2022) Glucocorticoid receptor antagonism upregulates somatostatin receptor subtype 2 expression in ACTH-producing neuroendocrine tumors: new insight based on the selective glucocorticoid receptor modulator relacorilant. Front Endocrinol (Lausanne) 12:793262

    Article  PubMed  Google Scholar 

  7. Munster PN, Greenstein AE, Fleming GF et al. (2022) Overcoming taxane resistance: preclinical and phase 1 studies of relacorilant, a selective glucocorticoid receptor modulator, with nab-paclitaxel in solid tumors. Clin Cancer Res 28(15):3214–3224

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unità di Endocrinologia, Azienda Ospedale-Università di Padova, Dipartimento di Medicina DIMED, Università degli Studi di Padova, Padova, Italia

    Alessandro Mondin, Carla Scaroni & Mattia Barbot

Authors
  1. Alessandro Mondin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carla Scaroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mattia Barbot
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mattia Barbot.

Ethics declarations

Conflitto di interesse

Gli autori Alessandro Mondin, Carla Scaroni e Mattia Barbot dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo articolo non hanno eseguito studi sugli animali.

Additional information

Proposto da C. Simeoli.

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mondin, A., Scaroni, C. & Barbot, M. Relacorilant, un nuovo bloccante selettivo del recettore dei glucocorticoidi. L'Endocrinologo 24, 555–557 (2023). https://doi.org/10.1007/s40619-023-01361-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-023-01361-z

Search

Navigation